Register
Community
Physicians
Editors
Experts
Code of conduct
Blog
Company
About
Publications
Press
Careers
Programs
Journal Club
Targeted Topic
Clinical Trial
Tumor Board
Contact Us
Sign in
The New England journal of medicine 2009-01-08
Glycemic control in patients with insulinoma treated with everolimus.
Related Questions
Do you have a preferred systemic agent for patients with metastatic, unresectable, functional neuroendocrine tumors, such as an insulinoma, if the goal is to get a quick response?
New comment
by Medical Oncologist at Bon Secours Saint Mary's Hospital ( July 22, 2021)
Thank you. This is very helpful!
Read more (3 Answers available)
10315
×
To continue please login or register
Register
or
Sign in